Alcantara Llaguno, S, Chen, J, Kwon, C-H, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009;15(1):45–56. https://doi.org/10.1016/j.ccr.2008.12.006.Google Scholar

Arita, H, Narita, Y, Fukushima, S, et al. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 2013;126(2):267–76. https://doi.org/10.1007/s00401-013-1141-6.CrossRefGoogle ScholarPubMed

Bao, S, Wu, Q, McLendon, RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444(7120):756–60. https://doi.org/10.1038/nature05236.CrossRefGoogle ScholarPubMed

Baron, JA, Gridley, G, Weiderpass, E, Nyrén, O, Linet, M. Venous thromboembolism and cancer. Lancet 1998;351(9109):1077–80. https://doi.org/10.1016/S0140-6736(97)10018-6.CrossRefGoogle ScholarPubMed

Cairncross, G, Wang, M, Shaw, E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 2013;31(3):337–43. https://doi.org/10.1200/JCO.2012.43.2674.CrossRefGoogle ScholarPubMed

Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455(7216):1061–8. https://doi.org/10.1038/nature07385.Google Scholar

Capper, D, Jones, DTW, Sill, M, et al. DNA methylation-based classification of central nervous system tumors. Nature 2018;555(7697):469–74. https://doi.org/10.1038/nature26000.CrossRefGoogle Scholar

Ceccarelli, M, Barthel, FP, Malta, TM, et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 2016;164(3):550–63. https://doi.org/10.1016/j.cell.2015.12.028.CrossRefGoogle ScholarPubMed

Chen, H, Judkins, J, Thomas, C, et al. Mutant IDH1 and seizures in patients with glioma. Neurology 2017;88(19):1805–13. https://doi.org/10.1212/WNL.0000000000003911.CrossRefGoogle ScholarPubMed

Dang, L, White, DW, Gross, S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009;462(7274):739–44. https://doi.org/10.1038/nature08617.Google Scholar

Dong, X, Noorbakhsh, A, Hirshman, BR, et al. Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: a SEER-based analysis. Neurooncol Pract 2016;3(1):29–38. https://doi.org/10.1093/nop/npv016.Google Scholar

Fecci, PE, Sampson, JH. The current state of immunotherapy for gliomas: an eye toward the future. J Neurosurg 2019;131(3):657–66. https://doi.org/10.3171/2019.5.JNS181762.Google Scholar

Figueroa, ME, Abdel-Wahab, O, Lu, C, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010;18(6):553–67. https://doi.org/10.1016/j.ccr.2010.11.015.CrossRefGoogle Scholar

Flavahan, WA, Drier, Y, Liau, BB, et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 2016;529(7584):110–4. https://doi.org/10.1038/nature16490.CrossRefGoogle ScholarPubMed

Fontebasso, AM, Liu, X-Y, Sturm, D, Jabado, N. Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail. Brain Pathol 2013;23(2):210–6. https://doi.org/10.1111/bpa.12023.Google Scholar

Galli, R, Binda, E, Orfanelli, U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64(19):7011–21. https://doi.org/10.1158/0008-5472.CAN-04-1364.Google Scholar

Gatta, G, Botta, L, Rossi, S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5 – a population-based study. Lancet Oncol 2014;15(1):35–47. https://doi.org/10.1016/S1470-2045(13)70548-5.Google Scholar

Gorovets, D, Kannan, K, Shen, R, et al. IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma. Clin Cancer Res 2012;18(9):2490–501. https://doi.org/10.1158/1078-0432.CCR-11-2977.Google Scholar

Grabowski, MM, Sankey, EW, Ryan, KJ, et al. Immune suppression in gliomas. J Neurooncol 2021;151(1):3–12. https://doi.org/10.1007/s11060-020-03483-y.CrossRefGoogle ScholarPubMed

Gusyatiner, O, Hegi, ME. Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol 2018;51:50–8. https://doi.org/10.1016/j.semcancer.2017.11.010.Google Scholar

Heaphy, CM, de Wilde, RF, Jiao, Y, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011;333(6041):425. https://doi.org/10.1126/science.1207313.Google Scholar

Hegi, ME, Diserens, A-C, Gorlia, T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352(10):997–1003. https://doi.org/10.1056/NEJMoa043331.Google Scholar

Horsted, F, West, J, Grainge, MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 2012;9(7):e1001275. https://doi.org/10.1371/journal.pmed.1001275.CrossRefGoogle Scholar

Jones, DTW, Hutter, B, Jäger, N, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 2013;45(8):927–32. https://doi.org/10.1038/ng.2682.CrossRefGoogle ScholarPubMed

Jones, DTW, Kocialkowski, S, Liu, L, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008;68(21):8673–7. https://doi.org/10.1158/0008-5472.CAN-08-2097.Google Scholar

Kreth, S, Thon, N, Kreth, FW. Epigenetics in human gliomas. Cancer Lett 2014;342(2):185–92. https://doi.org/10.1016/j.canlet.2012.04.008.CrossRefGoogle ScholarPubMed

Kroonen, J, Nassen, J, Boulanger, Y-G, et al. Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection. Int J Cancer 2011;129(3):574–85. https://doi.org/10.1002/ijc.25709.Google Scholar

Lee, JH, Lee, JE, Kahng, JY, et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 2018;560(7717):243–7. https://doi.org/10.1038/s41586-018-0389-3.Google Scholar

Liu, G, Yuan, X, Zeng, Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006;5:67. https://doi.org/10.1186/1476-4598-5-67.Google Scholar

Liubinas, SV, D’Abaco, GM, Moffat, BM, et al. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. Epilepsia 2014;55(9):1438–43. https://doi.org/10.1111/epi.12662.Google Scholar

Louis, DN, Perry, A, Reifenberger, G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131(6):803–20. https://doi.org/10.1007/s00401-016-1545-1.Google Scholar

Mandoj, C, Tomao, L, Conti, L. Coagulation in brain tumors: biological basis and clinical implications. Front Neurol 2019;10:181. https://doi.org/10.3389/fneur.2019.00181.CrossRefGoogle ScholarPubMed

Matarredona, ER, Pastor, AM. Neural stem cells of the subventricular zone as the origin of human glioblastoma stem cells. Therapeutic implications. Front Oncol 2019;9:779. https://doi.org/10.3389/fonc.2019.00779.Google Scholar

Nadi, M, Rutka, J. Molecular markers and pathways in brain tumorigenesis. In Bernstein, M, Berger, MS (Eds.), Neuro-Oncology: The Essentials, 3rd ed. Thieme Verlag, 2015, pp. 35–46.Google Scholar

Ohgaki, H, Kleihues, P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005;64(6):479–89. https://doi.org/10.1093/jnen/64.6.479.Google Scholar

Olson, JD, Riedel, E, DeAngelis, LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 2000;54(7):1442–8. https://doi.org/10.1212/wnl.54.7.1442.Google Scholar

Ostrom, QT, Gittleman, H, Liao, P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 2014;16(Suppl 4):iv1–63. https://doi.org/10.1093/neuonc/nou223.CrossRefGoogle ScholarPubMed

Pallud, J, Capelle, L, Huberfeld, G. Tumoral epileptogenicity: how does it happen? Epilepsia 2013;54(Suppl 9):30–4. https://doi.org/10.1111/epi.12440.Google Scholar

Papadopoulos, MC, Saadoun, S, Binder, DK, Manley, GT, Krishna, S, Verkman, AS. Molecular mechanisms of brain tumor edema. Neuroscience 2004;129(4):1011–20. https://doi.org/10.1016/j.neuroscience.2004.05.044.Google Scholar

Parker, M, Mohankumar, KM, Punchihewa, C, et al. C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 2014;506(7489):451–5. https://doi.org/10.1038/nature13109.CrossRefGoogle ScholarPubMed

Peng, Z, Liu, C, Wu, M. New insights into long noncoding RNAs and their roles in glioma. Mol Cancer 2018;17(1):61. https://doi.org/10.1186/s12943-018-0812-2.CrossRefGoogle ScholarPubMed

Portela, A, Esteller, M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28(10):1057–68. https://doi.org/10.1038/nbt.1685.CrossRefGoogle ScholarPubMed

Reifenberger, G, Louis, DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003;62(2):111–26. https://doi.org/10.1093/jnen/62.2.111.Google Scholar

Reifenberger, J, Ring, GU, Gies, U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 1996;55(7):822–31. https://doi.org/10.1097/00005072-199607000-00007.CrossRefGoogle ScholarPubMed

Reuss, DE, Mamatjan, Y, Schrimpf, D, et al. IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathol 2015;129(6):867–73. https://doi.org/10.1007/s00401-015-1438-8.Google Scholar

Ropper, AH, Samuels, MA, Klein, JP, Prasad, S. Intracranial neoplasms and paraneoplastic disorders. In: Adams and Victor’s Principles of Neurology, 11th ed. McGraw-Hill Education, 2019.Google Scholar

Samudra, N, Zacharias, T, Plitt, A, Lega, B, Pan, E. Seizures in glioma patients: an overview of incidence, etiology, and therapies. J Neurol Sci 2019;404:80–5. https://doi.org/10.1016/j.jns.2019.07.026.CrossRefGoogle ScholarPubMed

Sanai, N, Tramontin, AD, Quiñones-Hinojosa, A, et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 2004;427(6976):740–4. https://doi.org/10.1038/nature02301.Google Scholar

Sanson, M, Marie, Y, Paris, S, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 2009;27(25):4150–4. https://doi.org/10.1200/JCO.2009.21.9832.CrossRefGoogle ScholarPubMed

Schwartzentruber, J, Korshunov, A, Liu, X-Y, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012;482(7384):226–31. https://doi.org/10.1038/nature10833.Google Scholar

Shay, JW, Bacchetti, S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33(5):787–91. https://doi.org/10.1016/S0959-8049(97)00062-2.Google Scholar

Shi, J, Dong, B, Cao, J, et al. Long non-coding RNA in glioma: signaling pathways. Oncotarget 2017;8(16):27582–92. https://doi.org/10.18632/oncotarget.15175.Google Scholar

Singh, SK, Hawkins, C, Clarke, ID, et al. Identification of human brain tumor initiating cells. Nature 2004;432(7015):396–401. https://doi.org/10.1038/nature03128.Google Scholar

Stephens, PJ, Greenman, CD, Fu, B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011;144(1):27–40. https://doi.org/10.1016/j.cell.2010.11.055.Google Scholar

Stummer, W. Mechanisms of tumor-related brain edema. Neurosurg Focus 2007;22(5):E8. https://doi.org/10.3171/foc.2007.22.5.9.Google Scholar

Sullivan, JP, Nahed, BV, Madden, MW, et al. Brain tumor cells in circulation are enriched for mesenchymal gene expression. Cancer Discov 2014;4(11):1299–309. https://doi.org/10.1158/2159-8290.CD-14-0471.CrossRefGoogle ScholarPubMed

Takano, T, Lin, JH, Arcuino, G, Gao, Q, Yang, J, Nedergaard, M. Glutamate release promotes growth of malignant gliomas. Nat Med 2001;7(9):1010–5. https://doi.org/10.1038/nm0901-1010.CrossRefGoogle ScholarPubMed

Turcan, S, Rohle, D, Goenka, A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012;483(7390):479–83. https://doi.org/10.1038/nature10866.Google Scholar

Verhaak, RGW, Hoadley, KA, Purdom, E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17(1):98–110. https://doi.org/10.1016/j.ccr.2009.12.020.Google Scholar

Walker, A, West, J, Card, T, Crooks, C, Grainge, M. Rate of venous thromboembolism by cancer type compared to the general population using multiple linked databases. Thrombosis Res 2012;129:S155–6.Google Scholar

Watanabe, K, Sato, K, Biernat, W, et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 1997;3(4):523–30.Google ScholarPubMed

Wikstrand, CJ, Reist, CJ, Archer, GE, Zalutsky, MR, Bigner, DD. The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target. J Neurovirol 1998;4(2):148–58. https://doi.org/10.3109/13550289809114515.Google Scholar

Wu, G, Broniscer, A, McEachron, TA, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012;44(3):251–3. https://doi.org/10.1038/ng.1102.Google Scholar

Yan, H, Parsons, DW, Jin, G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360(8):765–73. https://doi.org/10.1056/NEJMoa0808710.Google Scholar

Zhang, J, Wu, G, Miller, CP, et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 2013;45(6):602–12. https://doi.org/10.1038/ng.2611.Google Scholar

Achrol, AS, Rennert, RC, Anders, C, et al. Brain metastases. Nat Rev Dis Primer 2019;5:1–26. https://doi.org/10.1038/s41572-018-0055-y.Google Scholar

Andreou, KE, Soto, MS, Allen, D, et al. Anti-inflammatory microglia/macrophages as a potential therapeutic target in brain metastasis. Front Oncol 2017;7:251. https://doi.org/10.3389/fonc.2017.00251.CrossRefGoogle ScholarPubMed

Berghoff, AS, Fuchs, E, Ricken, G, et al. Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. Oncoimmunology 2015;5(1):e1057388. https://doi.org/10.1080/2162402X.2015.1057388.Google Scholar

Berghoff, AS, Rajky, O, Winkler, F, et al. Invasion patterns in brain metastases of solid cancers. Neuro Oncol 2013;15:1664–72. https://doi.org/10.1093/neuonc/not112.Google Scholar

Berghoff, AS, Schur, S, Füreder, LM, et al. Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers. ESMO Open 2016; 1:e000024. https://doi.org/10.1136/esmoopen-2015-000024.Google Scholar

Besse, B, Moulec, SL, Mazières, J, et al. Bevacizumab in patients with nonsquamous non–small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study. Clin Cancer Res 2015;21:1896–903. https://doi.org/10.1158/1078-0432.CCR-14-2082.Google Scholar

Bi, P, Kuang, S. Notch signaling as a novel regulator of metabolism. Trends Endocrinol Metab 2015;26:248–55. https://doi.org/10.1016/j.tem.2015.02.006.Google Scholar

Blazquez, R, Wlochowitz, D, Wolff, A, et al. PI3 K: a master regulator of brain metastasis-promoting macrophages/microglia. Glia 2018;66;2438–55. https://doi.org/10.1002/glia.23485.CrossRefGoogle Scholar

Bohn, KA, Adkins, CE, Nounou, MI, Lockman, PR Inhibition of VEGF and angiopoietin-2 to reduce brain metastases of breast cancer burden. Front Pharmacol 2017;8:193. https://doi.org/10.3389/fphar.2017.00193.CrossRefGoogle ScholarPubMed

Bos, PD, Zhang, XH-F, Nadal, C, et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009;459:1005–09. https://doi.org/10.1038/nature08021.Google Scholar

Brastianos, PK, Carter, SL, Santagata, S, et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 2015;5:1164–77. https://doi.org/10.1158/2159-8290.CD-15-0369.CrossRefGoogle ScholarPubMed

Bucheit, AD, Chen, G, Siroy, A, et al. Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations. Clin Cancer Res 2014;20:5527–36. https://doi.org/10.1158/1078-0432.CCR-14-1027.Google Scholar

Cano, A, Pérez-Moreno, MA, Rodrigo, I, et al. The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76–83. https://doi.org/10.1038/35000025.Google Scholar

Chen, J, Lee, H-J, Wu, X, et al. Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. Cancer Res 2015;75:554–65. https://doi.org/10.1158/0008-5472.CAN-14-2268.Google Scholar

Chen, L, Douglass, J, Kleinberg, L, et al. Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. Int J Radiat Oncol 2018;100:916–25. https://doi.org/10.1016/j.ijrobp.2017.11.041.Google Scholar

Chen, Q, Boire, A, Jin, X, et al. Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 2016;533:493–8. https://doi.org/10.1038/nature18268.Google Scholar

Chongsathidkiet, P, Jackson, C, Koyama, S, et al. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nat Med 2018;24:1459–68. https://doi.org/10.1038/s41591-018-0135-2.Google Scholar

Choy, C, Ansari, KI, Neman, J, et al. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases. Breast Cancer Res 2017;19:51. https://doi.org/10.1186/s13058-017-0844-3.Google Scholar

Chuang, H-N, van Rossum, D, Sieger, D, et al. Carcinoma cells misuse the host tissue damage response to invade the brain. Glia 2013;61:1331–46. https://doi.org/10.1002/glia.22518.Google Scholar

Ciminera, AK, Jandial, R, Termini, J. Metabolic advantages and vulnerabilities in brain metastases. Clin Exp Metastasis 2017;34:401–10. https://doi.org/10.1007/s10585-017-9864-8.Google Scholar

Curley, CT, Sheybani, ND, Bullock, TN, Price, RJ. Focused ultrasound immunotherapy for central nervous system pathologies: challenges and opportunities. Theranostics 2017;7:3608–23. https://doi.org/10.7150/thno.21225.Google Scholar

Davies, MA, Liu, P, McIntyre, S, et al. Prognostic factors for survival in melanoma patients with brain metastases. Cancer 2011;117:1687–96. https://doi.org/10.1002/cncr.25634.Google Scholar

Di Giacomo, AM, Ascierto, PA, Queirolo, P, et al. Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study. Ann Oncol 2015;26:798–803. https://doi.org/10.1093/annonc/mdu577.Google Scholar

Di Giacomo, AM, Valente, M, Cerase, A, et al. Immunotherapy of brain metastases: breaking a “dogma”. J Exp Clin Cancer Res 2019;38:419. https://doi.org/10.1186/s13046-019-1426-2.Google Scholar

Dolgodilina, E, Imobersteg, S, Laczko, E, Welt, T, Verrey, F, Makrides, V. Brain interstitial fluid glutamine homeostasis is controlled by blood–brain barrier SLC7A5/LAT1 amino acid transporter. J Cereb Blood Flow Metab 2016;36:1929–41. https://doi.org/10.1177/0271678X15609331.Google Scholar

Eckert, MA, Lwin, TM, Chang, AT, et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011;19:372–86. https://doi.org/10.1016/j.ccr.2011.01.036.Google Scholar

Eichler, AF, Kahle, KT, Wang, DL, et al. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer. Neuro Oncol 2010;12:1193–9. https://doi.org/10.1093/neuonc/noq076.Google Scholar

Er, EE, Valiente, M, Ganesh, K, et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nat. Cell Biol 2018;20:966–78. https://doi.org/10.1038/s41556-018-0138-8.Google Scholar

Farber, SH, Tsvankin, V, Narloch, JL, et al. Embracing rejection: immunologic trends in brain metastasis. Oncoimmunology 2016;5:e1172153. https://doi.org/10.1080/2162402X.2016.1172153.Google Scholar

Fecci, PE, Champion, CD, Hoj, J, et al. The evolving modern management of brain metastasis. Clin Cancer Res 2019;25:6570–80. https://doi.org/10.1158/1078-0432.CCR-18-1624.Google Scholar

Fong, MY, Zhou, W, Liu, L, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 2015;17:183–94. https://doi.org/10.1038/ncb3094.Google Scholar

Gaudy-Marqueste, C, Dussouil, AS, Carron, R, et al. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery. Eur J Cancer 2017;84:44–54. https://doi.org/10.1016/j.ejca.2017.07.017.Google Scholar

Goldberg, SB, Gettinger, SN, Mahajan, A, et al. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol 2016;17:976–83. https://doi.org/10.1016/S1470-2045(16)30053-5.Google Scholar

Gong, X, Hou, Z, Endsley, MP, et al. Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes. npj Precis Oncol 2019;3:1–9. https://doi.org/10.1038/s41698-019-0094-1.Google Scholar

Gregory, PA, Bracken, CP, Smith, E, et al. An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial–mesenchymal transition. Mol Biol Cell 2011;22:1686–98. https://doi.org/10.1091/mbc.e11-02-0103.Google Scholar

Grimaldi, AM, Simeone, E, Giannarelli, D, et al. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. OncoImmunology 2014;3:e28780. https://doi.org/10.4161/onci.28780.Google Scholar

Hanna, N, Fidler, IJ. Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 1980;65:801–09. https://doi.org/10.1093/jnci/65.4.801.Google Scholar

Harter, PN, Bernatz, S, Scholz, A, et al. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases. Oncotarget 2015;6:40836–49.CrossRefGoogle ScholarPubMed

Herwig, N, Belter, B, Pietzsch, J. Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells. Biochem Biophys Res Commun 2016;477:963–9. https://doi.org/10.1016/j.bbrc.2016.07.009.Google Scholar

Hohensee, I, Lamszus, K, Riethdorf, S, et al. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases. Am J Pathol 2013;183:83–95. https://doi.org/10.1016/j.ajpath.2013.03.023.CrossRefGoogle ScholarPubMed

Hoj, JP, Mayro, B, Pendergast, AM. A TAZ-AXL-ABL2 feed-forward signaling axis promotes lung adenocarcinoma brain metastasis. Cell Rep 2019;29:3421–34. https://doi.org/10.1016/j.celrep.2019.11.018.CrossRefGoogle ScholarPubMed

Hong, JJ, Rosenberg, SA, Dudley, ME, et al. Successful treatment of melanoma brain metastases with adoptive cell therapy. Clin Cancer Res 2010;16:4892–8. https://doi.org/10.1158/1078-0432.CCR-10-1507.Google Scholar

Hoshino, A, Costa-Silva, B, Shen, T-L, et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015;527:329–35. https://doi.org/10.1038/nature15756.Google Scholar

Ilhan-Mutlu, A, Osswald, M, Liao, Y, et al. Bevacizumab prevents brain metastases formation in lung adenocarcinoma. Mol Cancer Ther 2016;15:702–10. https://doi.org/10.1158/1535-7163.MCT-15-0582.Google Scholar

Jackson, S, Anders, NM, Mangraviti, A, et al. The effect of regadenoson-induced transient disruption of the blood–brain barrier on temozolomide delivery to normal rat brain. J Neurooncol 2016;126:433–9. https://doi.org/10.1007/s11060-015-1998-4.Google Scholar

Jandial, R, Choy, C, Levy, DM, Chen, MY, Ansari, KI. Astrocyte-induced Reelin expression drives proliferation of Her2+ breast cancer metastases. Clin Exp Metastasis 2017;34:185–96. https://doi.org/10.1007/s10585-017-9839-9.Google Scholar

Jolly, MK, Somarelli, JA, Sheth, M, et al. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacol Ther 2019;194:161–84. https://doi.org/10.1016/j.pharmthera.2018.09.007.Google Scholar

Jung, YY, Kim, HM, Koo, JS. Expression of lipid metabolism-related proteins in metastatic breast cancer. PLoS One 2015;10:e0137204. https://doi.org/10.1371/journal.pone.0137204.Google Scholar

Kalluri, R, Weinberg, RA. The basics of epithelial–mesenchymal transition. J Clin Invest 2009;119:1420–8. https://doi.org/10.1172/JCI39104.Google Scholar

Kienast, Y, von Baumgarten, L, Fuhrmann, M, et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 2010;16:116–22. https://doi.org/10.1038/nm.2072.Google Scholar

Kim, AH, Tatter, S, Rao, G, et al. Laser ablation of abnormal neurological tissue using robotic neuroblate system (LAANTERN): 12-month outcomes and quality of life after brain tumor ablation. Neurosurgery 2020;87:E338–46. https://doi.org/10.1093/neuros/nyaa071.Google Scholar

Kim, S-J, Kim, J-S, Park, ES, et al. Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia 2011;13:286–98. https://doi.org/10.1593/neo.11112.Google Scholar

Kim, SW, Choi, HJ, Lee, H-J, et al. Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells. Neuro Oncol 2014;16:1585–98. https://doi.org/10.1093/neuonc/nou128.Google Scholar

Klein, A, Schwartz, H, Sagi-Assif, O, et al. Astrocytes facilitate melanoma brain metastasis via secretion of IL-23. J Pathol 2015;236:116–27. https://doi.org/10.1002/path.4509.Google Scholar

Kudo, Y, Haymaker, C, Zhang, J, et al. Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer. Ann Oncol 2019;30:1521–30. https://doi.org/10.1093/annonc/mdz207.Google Scholar

Labelle, M, Begum, S, Hynes, RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011;20:576–90. https://doi.org/10.1016/j.ccr.2011.09.009.Google Scholar

Lambert, AW, Pattabiraman, DR, Weinberg, RA. Emerging biological principles of metastasis. Cell 2017;168:670–91. https://doi.org/10.1016/j.cell.2016.11.037.Google Scholar

Lee, B-C, Lee, T-H, Avraham, S, Avraham, HK. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004;2:327–38.Google Scholar

Lee, JY, Park, K, Lee, E, et al. Gene expression profiling of breast cancer brain metastasis. Sci Rep 2016;6:28623. https://doi.org/10.1038/srep28623.Google Scholar

Lee, JY, Park, K, Lim, SH, et al. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget 2015;6:43731–42. https://doi.org/10.18632/oncotarget.6192Google Scholar

Lee, T-H, Avraham, HK, Jiang, S, Avraham, S. Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J Biol Chem 2003;278:5277–84. https://doi.org/10.1074/jbc.M210063200.Google Scholar

Leong, HS, Robertson, AE, Stoletov, K, et al. Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep 2014;8:1558–70. https://doi.org/10.1016/j.celrep.2014.07.050.Google Scholar

Leuthardt, EC, Duan, C, Kim, MJ, et al. Hyperthermic laser ablation of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain barrier. PLoS One 2016;11:e0148613. https://doi.org/10.1371/journal.pone.0148613.Google Scholar

Li, B, Wang, C, Zhang, Y, et al. Elevated PLGF contributes to small-cell lung cancer brain metastasis. Oncogene 2013;32:2952–62. https://doi.org/10.1038/onc.2012.313.Google Scholar

Li, B, Zhao, W-D, Tan, Z-M, Fang, W-G, Zhu, L, Chen, Y-H. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 2006;580:4252–60. https://doi.org/10.1016/j.febslet.2006.06.056.Google Scholar

Liberti, MV, Locasale, JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 2016;41:211–8. https://doi.org/10.1016/j.tibs.2015.12.001.Google Scholar

Lin, X, Lu, T, Xie, Z, et al. Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: a case report and literature review. Thorac Cancer 2019;10:1272–5. https://doi.org/10.1111/1759-7714.13048.Google Scholar

Liu, H, Kato, Y, Erzinger, SA, et al. The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model. BMC Cancer 2012;12:583. https://doi.org/10.1186/1471-2407-12-583.Google Scholar

Liu, H-L, Hua, M-Y, Chen, P-Y, et al. Blood–brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 2010;255:415–25. https://doi.org/10.1148/radiol.10090699.Google Scholar

Liu, Y, Cao, X. Characteristics and significance of the pre-metastatic niche. Cancer Cell 2016;30:668–81. https://doi.org/10.1016/j.ccell.2016.09.011.Google Scholar

Liu, Y, Kosaka, A, Ikeura, M, et al. Premetastatic soil and prevention of breast cancer brain metastasis. Neuro Oncol 2013;15:891–903. https://doi.org/10.1093/neuonc/not031.Google Scholar

Long, GV, Atkinson, V, Lo, S, et al. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol 2018;19:672–81. https://doi.org/10.1016/S1470-2045(18)30139-6.Google Scholar

Lorger, M, Felding-Habermann, B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol 2010;176:2958–71. https://doi.org/10.2353/ajpath.2010.090838.Google Scholar

Lorger, M, Krueger, JS, O’Neal, M, Staflin, K, Felding-Habermann, B. Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain,. PNAS 2009;106:10666–71. https://doi.org/10.1073/pnas.0903035106.Google Scholar

Louveau, A, Plog, BA, Antila, S, Alitalo, K, Nedergaard, M, Kipnis, J. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest 2017;127:3210–9. https://doi.org/10.1172/JCI90603.Google Scholar

Lowery, FJ, Yu, D. Brain metastasis: unique challenges and open opportunities. Biochim Biophys Acta 2017;1867:49–57. https://doi.org/10.1016/j.bbcan.2016.12.001.Google Scholar

Mani, SA, Guo, W, Liao, M-J, et al. The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704–15. https://doi.org/10.1016/j.cell.2008.03.027.Google Scholar

Margolin, K, Ernstoff, MS, Hamid, O, et al. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Lancet Oncol 2012;13:459–65. https://doi.org/10.1016/S1470-2045(12)70090-6.Google Scholar

Mashimo, T, Pichumani, K, Vemireddy, V, et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 2014;159:1603–14. https://doi.org/10.1016/j.cell.2014.11.025.Google Scholar

McFarland, BC, Benveniste, EN. Reactive astrocytes foster brain metastases via STAT3 signaling. Ann Transl Med 2019;7. https://doi.org/10.21037/atm.2019.04.17.Google Scholar

Menter, DG, Hatfield, JS, Harkins, C, et al. Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells. Clin Exp Metastasis 1987;5:65–78. https://doi.org/10.1007/BF00116627.Google Scholar

Morad, G, Carman, CV, Hagedorn, EJ, et al. Tumor-derived extracellular vesicles breach the intact blood–brain barrier via transcytosis. ACS Nano 2019;13:13853–65. https://doi.org/10.1021/acsnano.9b04397.Google Scholar

Moravan, MJ, Fecci, PE, Anders, CK, et al. Current multidisciplinary management of brain metastases. Cancer 2020;126:1390–406. https://doi.org/10.1002/cncr.32714.Google Scholar

Nakamura, T, Saito, R, Sugiyama, S, Sonoda, Y, Kumabe, T, Tominaga, T. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood–brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model. Cancer Lett 2011;310:77–83. https://doi.org/10.1016/j.canlet.2011.06.018.Google Scholar

Nam, D-H, Jeon, H-M, Kim, S, et al. Activation of notch signaling in a xenograft model of brain metastasis. Clin Cancer Res 2008;14:4059–66. https://doi.org/10.1158/1078-0432.CCR-07-4039.Google Scholar

Neman, J, Termini, J, Wilczynski, S, et al. Human breast cancer metastases to the brain display GABAergic properties in the neural niche. PNAS 2014;111:984–9. https://doi.org/10.1073/pnas.1322098111.Google Scholar

Ostrom, QT, Gittleman, H, Truitt, G, Boscia, A, Kruchko, C, Barnholtz-Sloan, JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncol 2018;20:iv1–iv86. https://doi.org/10.1093/neuonc/noy131.Google Scholar

Palumbo, JS, Talmage, KE, Massari, JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells. Blood 2005;105:178–85. https://doi.org/10.1182/blood-2004-06-2272.Google Scholar

Pastushenko, I, Brisebarre, A, Sifrim, A, et al. Identification of the tumour transition states occurring during EMT. Nature 2018;556:463–8. https://doi.org/10.1038/s41586-018-0040-3.Google Scholar

Pestalozzi, BC, Zahrieh, D, Price, KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 2006;17:935–44. https://doi.org/10.1093/annonc/mdl064.Google Scholar

Pfannenstiel, LW, McNeilly, C, Xiang, C, et al. Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma. OncoImmunology 2019;8:e1507669. https://doi.org/10.1080/2162402X.2018.1507669.Google Scholar

Priego, N, Zhu, L, Monteiro, C, et al. STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nat Med 2018;24:1024–35. https://doi.org/10.1038/s41591-018-0044-4.Google Scholar

Pukrop, T, Dehghani, F, Chuang, H-N, et al. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 2010;58:1477–89. https://doi.org/10.1002/glia.21022.Google Scholar

Qin, D, Ou, G, Mo, H, et al. Improved efficacy of chemotherapy for glioblastoma by radiation-induced opening of blood–brain barrier: clinical results. Int J Radiat Oncol 2001;51:959–62. https://doi.org/10.1016/S0360-3016(01)01735-7.Google Scholar

Qin, Y, Capaldo, C, Gumbiner, BM, Macara, IG. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 2005;171:1061–71. https://doi.org/10.1083/jcb.200506094.Google Scholar

Regmi, S, Fu, A, Luo, KQ. High shear stresses under exercise condition destroy circulating tumor cells in a microfluidic system. Sci Rep 2017;7:39975. https://doi.org/10.1038/srep39975.Google Scholar

Rizvi, NA, Mazières, J, Planchard, D, et al. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol 2015;16:257–65. https://doi.org/10.1016/S1470-2045(15)70054-9.Google Scholar

Rodrigues, G, Hoshino, A, Kenific, CM, et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat Cell Biol 2019;21:1403–12. https://doi.org/10.1038/s41556-019-0404-4.Google Scholar

Rolland, Y, Demeule, M, Fenart, L, Béliveau, R. Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface. Pigment Cell Melanoma Res 2009;22:86–98. https://doi.org/10.1111/j.1755-148X.2008.00525.x.Google Scholar

Salehi, A, Paturu, MR, Patel, B, et al. Therapeutic enhancement of blood–brain and blood–tumor barriers permeability by laser interstitial thermal therapy. Neurooncol Adv 2020;2:vdaa071. https://doi.org/10.1093/noajnl/vdaa071.Google Scholar

Sampson, JH, Gunn, MD, Fecci, PE, Ashley, DM. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer 2020;20:12–25. https://doi.org/10.1038/s41568-019-0224-7.Google Scholar

Sartorius, CA, Hanna, CT, Gril, B, et al. Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism. Oncogene 2016;35:2881–92. https://doi.org/10.1038/onc.2015.353.Google Scholar

Seike, T, Fujita, K, Yamakawa, Y, et al. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin Exp Metastasis 2011;28:13–25. https://doi.org/10.1007/s10585-010-9354-8.Google Scholar

Sevenich, L, Bowman, RL, Mason, SD, et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol 2014;16:876–88. https://doi.org/10.1038/ncb3011.Google Scholar

Sharma, M, Balasubramanian, S, Silva, D, Barnett, GH, Mohammadi, AM. Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: an overview. Expert Rev Neurother 2016;16:223–32. https://doi.org/10.1586/14737175.2016.1135736.Google Scholar

Silver, IA, Erecińska, M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci 1994;14:5068–76. https://doi.org/10.1523/JNEUROSCI.14-08-05068.1994.Google Scholar

Sjøbakk, TE, Johansen, R, Bathen, TF, et al. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3 T. BMC Cancer 2007;7:141. https://doi.org/10.1186/1471-2407-7-141.Google Scholar

Sjøbakk, TE, Vettukattil, R, Gulati, M, et al. Metabolic profiles of brain metastases. Int J Mol Sci 2013;14:2104–18. https://doi.org/10.3390/ijms14012104.Google Scholar

Soto, MS, Serres, S, Anthony, DC, Sibson, NR. Functional role of endothelial adhesion molecules in the early stages of brain metastasis. Neuro Oncol 2014;16:540–51. https://doi.org/10.1093/neuonc/not222.Google Scholar

Sperringer, JE, Addington, A, Hutson, SM. Branched-chain amino acids and brain metabolism. Neurochem Res 2017;42:1697–709. https://doi.org/10.1007/s11064-017-2261-5.Google Scholar

Tabatabaei, SN, Girouard, H, Carret, A-S, Martel, S. Remote control of the permeability of the blood–brain barrier by magnetic heating of nanoparticles: a proof of concept for brain drug delivery. J Control Release 2015;206:49–57. https://doi.org/10.1016/j.jconrel.2015.02.027.Google Scholar

Tawbi, HA, Forsyth, PA, Algazi, A, et al. Combined Nivolumab and Ipilimumab in melanoma metastatic to the brain. N Engl J Med 2018;379:722–30. https://doi.org/10.1056/NEJMoa1805453.Google Scholar

Théry, C, Zitvogel, L, Amigorena, S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002;2:569–79. https://doi.org/10.1038/nri855.Google Scholar

Tiwary, S, Morales, JE, Kwiatkowski, SC, Lang, FF, Rao, G, McCarty, JH. Metastatic brain tumors disrupt the blood–brain barrier and alter lipid metabolism by inhibiting expression of the endothelial cell fatty acid transporter Mfsd2a. Sci Rep 2018;8:8267. https://doi.org/10.1038/s41598-018-26636-6.Google Scholar

Tominaga, N, Kosaka, N, Ono, M, et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier. Nat Commun 2015;6:6716. https://doi.org/10.1038/ncomms7716.Google Scholar

Tyran, M, Carbuccia, N, Garnier, S, et al. A comparison of DNA mutation and copy number profiles of primary breast cancers and paired brain metastases for identifying clinically relevant genetic alterations in brain metastases. Cancers 2019;11:665. https://doi.org/10.3390/cancers11050665.Google Scholar

Valiente, M, Obenauf, AC, Jin, X, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014;156:1002–16. https://doi.org/10.1016/j.cell.2014.01.040.Google Scholar

van Vulpen, M, Kal, HB, Taphoorn, MJB, El Sharouni, SY. Changes in blood–brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? Oncol Rep 2002;9:683–8. https://doi.org/10.3892/or.9.4.683.Google Scholar

Wagner, S, Czub, S, Greif, M, et al. Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int J Cancer 1999;82:12–6. https://doi.org/10.1002/(sici)1097-0215(19990702)82:1<12::aid-ijc3>3.0.co;2-o.Google Scholar

Wang, H, Ou, Q, Li, D, et al. Genes associated with increased brain metastasis risk in non–small cell lung cancer: comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036). Cancer 2019;125:3535–44. https://doi.org/10.1002/cncr.32372.Google Scholar

Warburg, O. The metabolism of carcinoma cells. J Cancer Res 1925;9:148–63. https://doi.org/10.1158/jcr.1925.148.Google Scholar

Wu, YJ, Muldoon, LL, Gahramanov, S, Kraemer, DF, Marshall, DJ, Neuwelt, EA. Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model. J Neurooncol 2012;110:27–36. https://doi.org/10.1007/s11060-012-0942-0.Google Scholar

Xing, F, Kobayashi, A, Okuda, H, et al. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol Med 2013;5:384–96. https://doi.org/10.1002/emmm.201201623.Google Scholar

Xing, F, Liu, Y, Sharma, S, et al. Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer. Cancer Res 2016;76:4970–80. https://doi.org/10.1158/0008-5472.CAN-15-3541.Google Scholar

Xing, F, Liu, Y, Wu, S-Y, et al. Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal microRNA to promote brain metastasis. Cancer Res 2018;78:4316–30. https://doi.org/10.1158/0008-5472.CAN-18-1102.Google Scholar

Yang, J, Mani, SA, Donaher, JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927–39. https://doi.org/10.1016/j.cell.2004.06.006.Google Scholar

Yang, X, Di, J, Zhang, Y, et al. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer. Biomed Pharmacother 2012;66:221–7. https://doi.org/10.1016/j.biopha.2011.11.011.Google Scholar

Yano, S, Shinohara, H, Herbst, RS, et al. Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res 2000;60:4959–67.Google Scholar

Yao, H, Price, TT, Cantelli, G, et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature 2018;560:55–60. https://doi.org/10.1038/s41586-018-0342-5.Google Scholar

Yu, M, Bardia, A, Wittner, BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580–4. https://doi.org/10.1126/science.1228522.Google Scholar

Yuan, H, Gaber, MW, Boyd, K, Wilson, CM, Kiani, MF, Merchant, TE. Effects of fractionated radiation on the brain vasculature in a murine model: blood–brain barrier permeability, astrocyte proliferation, and ultrastructural changes. Int J Radiat Oncol Biol Phys 2006;66:860–6. https://doi.org/10.1016/j.ijrobp.2006.06.043.Google Scholar

Zhang, L, Zhang, S, Yao, J, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 2015;527:100–04. https://doi.org/10.1038/nature15376.Google Scholar

Abbud, RA, Takumi, I, Barker, EM, et al. Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol Endocrinol 2005;19(5):1383–91. https://doi.org/10.1210/me.2004-0403.CrossRefGoogle ScholarPubMed

Abedalthagafi, M, Bi, WL, Aizer, AA, et al. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol 2016;18(5):649–55. https://doi.org/10.1093/neuonc/nov316.Google Scholar

An, J, Pei, X, Zang, Z, et al., Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells. Oncotarget 2017:8(23):37538–49. https://doi.org/10.18632/oncotarget.16556.Google Scholar

Apps, JR, Martinez-Barbera, JP. Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biology. Brain Pathol. 2017 May;27(3):364–369. doi: 10.1111/bpa.12501.Google Scholar

Asa, SL, Kovacs, K, Stefaneanu, L, et al., Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 1992;131(5):2083–9. https://doi.org/10.1210/endo.131.5.1425411.Google Scholar

Aziz-Bose, R, Monje, M. Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets. Curr Opin Oncol 2019;31(6):522–30. https://doi.org/10.1097/CCO.0000000000000577.Google Scholar

Bai, F, Chan, HL, Smith, MD, Kiyokawa, H, Pei, X-H. p19^Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation. Mol Cell Biol 2014;34(12):2121–34. https://doi.org/10.1128/MCB.01363-13.Google Scholar

Bentley, L, Esapa, CT, Nesbit, MA, et al. An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess. Endocrinology 2014;155(3):908–22. https://doi.org/0.1210/en.2013-1247.Google Scholar

Bertolino, P, Tong, W-M, Herrera, PL, et al. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res 2003;63(16):4836–41.Google Scholar

Bi, WL, Abedalthagafi, M, Horowitz, P, et al. Genomic landscape of intracranial meningiomas. J Neurosurg 2016a;125(3):525–35. https://doi.org/10.3171/2015.6.JNS15591.Google Scholar

Bi, WL, Mei, Y, Agarwalla, PK, Beroukhim, R, Dunn, IF. Genomic and epigenomic landscape in meningioma. Neurosurg Clinics 2016b;27(2):167–79. https://doi.org/10.1016/j.nec.2015.11.009.Google Scholar

Biondi, CA, Gartside, MG, Waring, P, et al. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Mol Cell Biol 2004;24(8):3125–31. https://doi.org/10.1128/MCB.24.8.3125-3131.2004.Google Scholar

Booth, A, Trudeau, T, Gomez, C, Lucia, MS, Gutierrez-Hartmann, A. Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype. Mol Endocrinol 2014;28(12):1999–2011. https://doi.ord/10.1210/me.2014-1168.Google Scholar

Cai, DX, Banerjee, R, Scheithauer, BW, Lohse, CM, Kleinschmidt-Demasters, BK, Perry, A. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 2001;60(6):628–36. https://doi.org/10.1093/jnen/60.6.628.Google Scholar

Chang, LS, Welling, DB. Molecular biology of vestibular schwannomas. Methods Mol Biol 2009;493:163–77. https://doi.org/10.1007/978-1-59745-523-7_10.Google Scholar

Cheng, SQ, Fan, H-Y, Xu, X, et al, Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro. J Huazhong Univ Sci Technolog Med Sci 2016;36(4):558–63. https://doi.org/10.1007/s11596-016-1625-4.Google Scholar

Chesnokova, V, Kovacs, K, Castro, A-V, Zonis, S, Melmed, S. Pituitary hypoplasia in Pttg–/– mice is protective for Rb+/– pituitary tumorigenesis. Mol Endocrinol 2005;19(9):2371–9. https://doi.org/10.1210/me.2005-0137.Google Scholar

Choudhury, A, Raleigh, DR. Preclinical models of meningioma: cell culture and animal systems. Handb Clin Neurol 2020;169:131–6. https://doi.org/10.1016/B978-0-12-804280-9.00008-1.Google Scholar

Chukwueke, UN, Wen, PY. Medical management of meningiomas. In MW, McDermott (Ed.), Handbook of Clinical Neurology. Elsevier, 2020: pp. 291–302.Google Scholar

Chung PED, Gendoo DMA, Ghanbari-Azarnier, R, Liu, JC, Jiang, Z, Tsui J, Wang DY, Xiao X, Li B, Dubuc A, Shih D, Remke M, Ho B, Garzia L, Ben-David Y, Kang SG, Croul S, Haibe-Kains B, Huang A, Taylor MD, Zacksenhaus E. Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy. Nat Commun. 2020 Apr 14;11(1):1825. doi: 10.1038/s41467-020-15585-2.Google Scholar

Chunharojrith, P, Nakayama, Y, Jiang, X, et al., Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line. Mol Cell Endocrinol 2015;416:27–35. https://doi.org/10.1016/j.mce.2015.08.018.Google Scholar

Clark, VE, Erson-Omay, EZ, Serin, A, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013;339(6123):1077–80. https://doi.org/10.1126/science.1233009.Google Scholar

Crabtree, JS, Scacheri, PC, Ward, JM, et al. Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 2003;23(17):6075–85. https://doi.org/10.1128/MCB.23.17.6075-6085.2003.Google Scholar

de Vries, M, van der Mey, AG, Hogendoorn, PC. Tumor biology of vestibular Schwannoma: a review of experimental data on the determinants of tumor genesis and growth characteristics. Otol Neurotol 2015;36(7):1128–36. https://doi.org/10.1097/MAO.0000000000000788.Google Scholar

Donangelo, I, Gutman, S, Horvath, E, et al. Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 2006;147(10):4781–91. https://doi.org/10.1210/en.2006-0544.Google Scholar

Ezzat, S, Zheng, L, Winer, D, Asa, SL. Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications. Mol Endocrinol 2006;20(11):2965–75. https://doi.org/10.1210/me.2006-0223.Google Scholar

Fangusaro, J. Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology. Front Oncol 2012;2:105. https://doi.org/10.3389/fonc.2012.00105.Google Scholar

Favero, G, Bonomini, F, Rezzani, R. Pineal gland tumors: a review. Cancers (Basel) 2021;13(7):1547. https://doi.org/10.3390/cancers13071547.Google Scholar

Fedele, M, Battista, S, Kenyon, L, et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002;21(20):3190–8. https://doi.org/10.1038/sj.onc.1205428.Google Scholar

Fedele, M, Pentimalli, F, Baldassarre, G, et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005;24(21):3427–35. https://doi.org/10.1038/sj.onc.1208501.Google Scholar

Fedele, M, Visone, R, De Martino, I, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006;9(6):459–71. https://doi.org/10.1016/j.ccr.2006.04.024Google Scholar

Franklin, DS, Godfrey, VL, Lee, H, et al. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 1998;12(18):2899–911. https://doi.org/10.1101/gad.12.18.2899.Google Scholar

Fuertes, M, Sapochnik, M, Tedesco, L, et al. Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity. Endocr Relat Cancer 2018;25(6):665–76. https://doi.org/10.1530/ERC-18-0028.Google Scholar

Gahete, MD, Jiménez-Vacas, JM, Alors-Pérez, E, et al. Mouse models in endocrine tumors. J Endocrinol 2019;240(3):R73–93. https://doi.org/10.1530/JOE-18-0571CrossRefGoogle Scholar

Greene, HSN, Arnold, H. The homologous and heterologous transplantation of brain and brain tumors. J Neurosurg 1945;2(4):315–31. https://doi.org/10.3171/jns.1945.2.4.0315.Google Scholar

Guidi, CJ, Mudhasani, R, Hoover, K, et al. Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis. Cancer Res 2006;66(16):8076–82. https://doi.org/10.1158/0008-5472.CAN-06-1451.Google Scholar

Harvey, M, Vogel, H, Lee, EY, Bradley, A, Donehower, LA. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 1995;55(5):1146–51.Google Scholar

Helseth, A, Siegel, GP, Haug, E, Bautch, VL. Transgenic mice that develop pituitary tumors. A model for Cushing’s disease. Am J Pathol 1992;140(5):1071–80.Google Scholar

Hemmer, S, Sippl, C, Sahm, F, Oertel, J, Urbschat, S, Ketter, R. The loss of 1p as a reliable marker of progression in a child with aggressive meningioma: a 16-year follow-up case report. Ped Neurosurg 2020;55(6):418–25. https://doi.org/10.1159/000512001.Google Scholar

Hirato, J, Nakazato, Y. Pathology of pineal region tumors. J Neurooncol 2001;54(3):239–49. https://doi.org/10.1023/a:1012721723387.Google Scholar

Jacks, T, Fazeli, A, Schmitt, EM, Bronson, RT, Goodell, MA, Weinberg, RA. Effects of an Rb mutation in the mouse. Nature 1992:359(6393):295–300. https://doi.org/10.1038/359295a0.Google Scholar

Jalali, S, Monsalves, E, Tateno, T, Zadeh, G. Role of mTOR inhibitors in growth hormone-producing pituitary adenomas harboring different FGFR4 genotypes. Endocrinology 2016;157(9):3577–87. https://doi.org/10.1210/en.2016-1028.Google Scholar

James, MF, Han, S, Polizzano, C, et al. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol 2009;29(15):4250–61. https://doi.org/10.1128/MCB.01581-08.Google Scholar

Johung, TB, Monje, M. Diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets. Curr Neuropharmacol 2017;15(1):88–97. https://doi.org/10.2174/1570159x14666160509123229.Google Scholar

Kalamarides, M, Niwa-Kawakita, M, Leblois, H, et al. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev 2002;16(9):1060–5. https://doi.org/10.1101/gad.226302.Google Scholar

Kiyokawa, H, Kineman, RD, Manova-Todorova, KO, et al., Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996;85(5):721–32. https://doi.org/10.1016/s0092-8674(00)81238-6.Google Scholar

Kumar, TR, Graham, KE, Asa, SL, Low, MJ. Simian virus 40 T antigen-induced gonadotroph adenomas: a model of human null cell adenomas. Endocrinology 1998:139(7):3342–51. https://doi.org/10.1210/endo.139.7.6100.Google Scholar

Lee, Y, Liu, J, Patel, S, et al. Genomic landscape of meningiomas. Brain Pathol 2010;20(4):751–62. https://doi.org/10.1111/j.1750-3639.2009.00356.x.Google Scholar

Li, R, Zhang, Z, Wang, J, et al. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway. Biomed Pharmacother 2017;95:771–9. https://doi.org/10.1016/j.biopha.2017.08.127.Google Scholar

Lin, SJ, Wu, ZR, Cao, L, et al. Pituitary tumor suppression by combination of cabergoline and chloroquine. J Clin Endocrinol Metab 2017;102(10):3692–703. https://doi.org/10.1210/jc.2017-00627.Google Scholar

Lloyd, RV, Ruebel, KH, Zhang, S, Jin, L. Pituitary hyperplasia in glycoprotein hormone alpha subunit-, p18(INK4C)-, and p27(kip-1)-null mice: analysis of proteins influencing p27(kip-1) ubiquitin degradation. Am J Pathol 2002;160(3): 1171–9. https://doi.org/10.1016/S0002-9440(10)64936-X.Google Scholar

Loffler, KA, Biondi, CA, Gartside, MG, et al. Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice. Oncogene 2007;26(27):4009–17. https://doi.org/10.1038/sj.onc.1210163.Google Scholar

Louis, DN, Perry, A, Wesseling, P, et al. The 2021 WHO Classi cation of Tumors of the Central Nervous System: a summary. Neuro-Oncology. 2021;23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106.Google Scholar

Low, MJ, Liu, B, Hammer, GD, Rubinstein, M, Allen, RG. Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene. J Biol Chem 1993;268(33):24967–75.Google Scholar

Lu, J, Chatain, GP, Bugarini, A, et al. Histone deacetylase inhibitor SAHA is a promising treatment of cushing disease. J Clin Endocrinol Metab 2017;102(8):2825–35. 10.1210/jc.2017-00464.Google Scholar

Mannelli, M, Cantini, G, Poli, G, et al. Role of the PPAR-γ system in normal and tumoral pituitary corticotropic cells and adrenal cells. Neuroendocrinology 2010;92(Suppl 1):23–7. https://doi.org/10.1159/000314312.Google Scholar

Manoranjan, B, Mahendram, S, Almenawer, SA, et al. The identification of human pituitary adenoma-initiating cells. Acta Neuropathol Commun 2016;4(1):125. https://doi.org/10.1186/s40478-016-0394-4.Google Scholar

McClatchey, AI, Saotome, I, Mercer, K, et al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 1998;12(8):1121–33. https://doi.org/10.1101/gad.12.8.1121.Google Scholar

McCutcheon, IE, Friend, KE, Gerdes, TM, Zhang, BM, Wildrick, DM, Fuller, GN. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth. J Neurosurg 2000;92(2):306–14. https://doi.org/10.3171/jns.2000.92.2.0306.Google Scholar

McSheehy, PM, Troy, H, Kelland, LR, Judson, IR, Leach, MO, Griffiths, JR. Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics. Eur J Cancer 2003;39(4):532–40. 10.1016/s0959-8049(02)00671-8.Google Scholar

Millard, NE, De Braganca, KC. Medulloblastoma. J Child Neurol 2016;31(12):1341–53. https://doi.org/10.1177/0883073815600866. Erratum in J Child Neurol, 2016.Google Scholar

Morrison, JP, Satoh, H, Foley, J, et al. N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)/p19(ARF) tumor suppressor gene-deficient mice. Toxicol Pathol 2007;35(6):780–7. https://doi.org/10.1080/01926230701584130.Google Scholar

Müller, HL. Craniopharyngioma. Endocr Rev 2014;35(3):513–43. https://doi.org/10.1210/er.2013-1115.Google Scholar

Müller, HL, Merchant, TE, Warmuth-Metz, M, Martinez-Barbera, JP, Puget, S. Craniopharyngioma. Nat Rev Dis Primers 2019;5(1):75. https://doi.org/10.1038/s41572-019-0125-9.Google Scholar

Nakayama, K, Ishida, N, Shirane, M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85(5):707–20. https://doi.org/10.1016/s0092-8674(00)81237-4.Google Scholar

Ning, S, Knox, SJ, Harsh, GR, Culler, MD, Katznelson, L. Lanreotide promotes apoptosis and is not radioprotective in GH3 cells. Endocr Relat Cancer 2009;16(3):1045–55. https://doi.org/10.1677/ERC-09-0003.Google Scholar

Northcott, PA, Robinson, GW, Kratz, CP, et al. Medulloblastoma. Nat Rev Dis Primers 2019;5(1):11. https://doi.org/10.1038/s41572-019-0063-6.Google Scholar

Ostrom, QT, Patil, N, Cioffi, G, Waite, K, Kruchko, C, Barnholtz-Sloan, JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro-Oncology 2020;22(Suppl_1):iv1–96. https://doi.org/10.1093/neuonc/noaa200.Google Scholar

Pei, L, Melmed, S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997;11(4):433–41. https://doi.org/10.1210/mend.11.4.9911.Google Scholar

Petrilli, AM, Fernández-Valle, C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene 2016;35(5):537–48. https://doi.org/10.1038/onc.2015.125.Google Scholar

Peyre, M, Salaud, C, Clermont-Taranchon, E, et al. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Oncotarget 2015;6(32):32713–22. https://doi.org/10.18632/oncotarget.5296.Google Scholar

Plant-Fox, AS, O’Halloran, K, Goldman, S. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae. Curr Probl Cancer 2021;45(4):100777. https://doi.org/10.1016/j.currproblcancer.2021.100777.Google Scholar

Raitila, A, Lehtonen, HJ, Arola, J, et al. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression. Am J Pathol 2010;177(4):1969–76. https://doi.org/10.2353/ajpath.2010.100138.Google Scholar

Rath, P, Miller, DC, Litofsky, NS, et al. Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma. Exp Mol Pathol 2011;90(2):179–88. https://doi.org/10.1016/j.yexmp.2010.12.003.Google Scholar

Reni, M, Gatta, G, Mazza, E, Vecht, C. Ependymoma. Crit Rev Oncol Hematol 2007;63(1):81–9. https://doi.org/10.1016/j.critrevonc.2007.03.004.Google Scholar

Reuss, DE, Piro, RM, Jones, DTW, et al. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 2013;125(3):351–8. https://doi.org/10.1007/s00401-013-1093-x.Google Scholar

Roche, C, Rasolonjanahary, R, Thirion, S, et al. Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells. Hum Gene Ther 2012;23(1):104–14. https://doi.org/10.1089/hum.2011.105.Google Scholar

Roussel-Gervais, A, Bilodeau, S, Vallette, S, et al. Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis. Mol Endocrinol 2010;24(9):1835–45. https://doi.org/10.1210/me.2010-0091.Google Scholar

Russell, WL, Kelly, EM, Hunsicker, PR, Bangham, JW, Maddux, SC, Phipps, EL. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. PNAS 1979;76(11):5818–9. https://doi.org/10.1073/pnas.76.11.5818.Google Scholar

Sáez, C, Japón, MA, Ramos-Morales, F, et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 1999;18(39):5473–6. https://doi.org/10.1038/sj.onc.1202914.Google Scholar

Seizinger, BR, de la Monte, S, Atkins, L, Gusella, JF, Martuza, RL. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. PNAS 1987;84(15):5419–23. https://doi.org/10.1073/pnas.84.15.5419.Google Scholar

Shapiro, IM, Kolev, VN, Vidal, CM, et al. Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship. Sci Transl Med 2014;6(237):237ra68–237ra68. https://doi.org/10.1126/scitranslmed.3008639.Google Scholar

Sotillo, R, Renner, O, Dubus, P, et al., Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res, 2005. 65(9): p. 3846-52. https://doi.org/10.1158/0008-5472.CAN-04-4195.Google Scholar

Stefaneanu, L, Rindi, G, Horvath, E, Murphy, D, Polak, JM, Kovacs, K. Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene. Endocrinology 1992;130(4):1789–95. https://doi.org/10.1210/endo.130.4.1312426.Google Scholar

Stenzel-Poore, MP, Cameron, VA, Vaughan, J, Sawchenko, PE, Vale, W. Development of Cushing’s syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 1992;130(6):3378–86. https://doi.org/10.1210/endo.130.6.1597149.Google Scholar

Suppiah, S, Nassiri, F, Bi, WL, et al. Molecular and translational advances in meningiomas. Neuro Oncol 2019;21(Suppl_1):i4–17. https://doi.org/10.1093/neuonc/noy178.Google Scholar

Thomas, C, Soschinski, P, Zwaig, M, et al. The genetic landscape of choroid plexus tumors in children and adults. Neuro Oncol 2021;23(4):650–60. 10.1093/neuonc/noaa267.Google Scholar

Torp SH, Solheim O, Skjulsvik AJ. The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know-a minireview. Acta Neurochir (Wien). 2022 Sep;164(9):2453–2464. doi: 10.1007/s00701-022-05301-y.Google Scholar

Tsai, KY, MacPherson, D, Rubinson, DA, et al., ARF mutation accelerates pituitary tumor development in Rb+/– mice. PNAS 2002;99(26):16865–70. https://doi.org/10.1073/pnas.262499599.Google Scholar

Vierimaa, O, Georgitsi, M, Lehtonen, R, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006;312(5777):1228–30. https://doi.org/10.1126/science.1126100.Google Scholar

Vlotides, G, Eigler, T, Melmed, S. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev 2007;28(2):165–86. https://doi.org/Google Scholar

Vooijs, M, van der Valk, M, te Riele, H, Berns, A. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 1998;17(1):1–12. https://doi.org/10.1038/sj.onc.1202169.Google Scholar

Wang, D, Wong, H-K, Feng, Y-B, Zhang, Z-J. Liquiritigenin exhibits antitumour action in pituitary adenoma cells via Ras/ERKs and ROS-dependent mitochondrial signalling pathways. J Pharm Pharmacol 2014;66(3):408–17. https://doi.org/10.1111/jphp.12170.Google Scholar

Wolff, JE, Sajedi, M, Brant, R, Coppes, MJ, Egeler, RM. Choroid plexus tumours. Br J Cancer 2002;87(10):1086–91. https://doi.org/10.1038/sj.bjc.6600609.Google Scholar

Wu, J, Armstrong, TS, Gilbert, MR. Biology and management of ependymomas. Neuro Oncol 2016;18(7):902–13. https://doi.org/10.1093/neuonc/now016.Google Scholar

Yin, Z, Williams-Simons, L, Parlow, AF, Asa, S, Kirschner, LS. Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 2008;22(2):380–7. https://doi.org/10.1210/me.2006-0428.Google Scholar

Youngblood, MW, Duran, D, Montejo, JD, et al. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg 2019;133(5):1345–54. https://doi.org/10.3171/2019.8.JNS191266.Google Scholar

Zang, KD, Singer, H. Chromosomal constitution of meningiomas. Nature 1967;216(5110):84–5. https://doi.org/10.1038/216084a0.Google Scholar

Zhang, H, Qi, L, Du, Y, et al. Patient-derived orthotopic xenograft (PDOX) mouse models of primary and recurrent meningioma. Cancers (Basel) 2020;12(6):E1478. https://doi.org/10.3390/cancers12061478.Google Scholar

Zhao, Y, Xiao, Z, Chen, W, Yang, J, Li, T, Fan, B. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression. Mol Med Rep 2015;12(2):2313–22. https://doi.org/10.3892/mmr.2015.3664.Google Scholar

Zhen, W, Qiu, D, Zhiyong, C, et al. MicroRNA-524-5p functions as a tumor suppressor in a human pituitary tumor-derived cell line. Horm Metab Res 2017;49(7):550–7. https://doi.org/10.1055/s-0043-106437.Google Scholar

Zindy, F, Nilsson, LM, Nguyen, L, et al. Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice. Cancer Res 2003;63(17):5420–7.Google Scholar

Abode-Iyamah, K, Kim, SB, Grosland, N, et al. Spinal motion and intradiscal pressure measurements before and after lumbar spine instrumentation with titanium or PEEK rods. J Clin Neurosci 2014;21:651–5. https://doi.org/10.1016/j.jocn.2013.08.010.Google Scholar

Bell, GH, Dunbar, O, Beck, JS, Gibb, A. Variations in strength of vertebrae with age and their relation to osteoporosis. Calcif Tissue Res 1967;1(1):75–86. https://doi.org/10.1007/BF02008077.Google Scholar

Brown, T, Hansen, RJ, Yorra, AJ Some mechanical tests on the lumbosacral spine with particular reference to the intervertebral discs; a preliminary report. J Bone Joint Surg Am 1957;39-A(5):1135–64.Google Scholar

Denis, F. The three column spine and its significance in the classification of acute thoracolumbar spinal injuries. Spine 1983;8:817–31. https://doi.org/10.1097/00007632-198311000-00003.Google Scholar

Gregersen, GG, Lucas, DB. An in vivo study of the axial rotation of the human thoracolumbar spine. J Bone Joint Surg Am 1967;49:247–62.Google Scholar

Hirsch, C. The reaction of intervertebral discs to compression forces. J Bone Joint Surg Am 1955;37-A:1188–96.Google Scholar

Lysell, E. Motion in the cervical spine. An experimental study on autopsy specimens. Acta Orthop Scand Suppl 1969;123:1+. https://doi.org/10.3109/ort.1969.40.suppl-123.01.Google Scholar

Markolf, KL. Deformation of the thoracolumbar intervertebral joints in response to external loads: a biomechanical study using autopsy material. J Bone Joint Surg Am 1972;54:511–33.Google Scholar

Markolf, KL, Morris, JM. The structural components of the intervertebral disc. A study of their contributions to the ability of the disc to withstand compressive forces. J Bone Joint Surg Am 1974;56:675–87.Google Scholar

Miele, VJ, Panjabi, MM, Benzel, EC. Anatomy and biomechanics of the spinal column and cord. Handb Clin Neurol 2012;109:31–43. https://doi.org/10.1016/B978-0-444-52137-8.00002-4.Google Scholar

Nachemson, A. The load on lumbar disks in different positions of the body. Clin Orthop 1966;45:107–22.Google Scholar

Nachemson, A, Morris, JM. In vivo measurements of intradiscal pressure. Discometry, a method for the determination of pressure in the lower lumbar discs. J Bone Joint Surg Am 1964;46:1077–92.Google Scholar

Noyes, FR, DeLucas, JL, Torvik, PJ. Biomechanics of anterior cruciate ligament failure: an analysis of strain-rate sensitivity and mechanisms of failure in primates. J Bone Joint Surg Am 1974a;56:236–53.Google Scholar

Noyes, FR, Torvik, PJ, Hyde, WB, DeLucas, JL. Biomechanics of ligament failure. II. An analysis of immobilization, exercise, and reconditioning effects in primates. J Bone Joint Surg Am 1974b;56:1406–18.Google Scholar

Panjabi, MM. The stabilizing system of the spine. Part II. Neutral zone and instability hypothesis. J Spinal Disord 1992;5:390–6; discussion 397. https://doi.org/10.1097/00002517-199212000-00002.Google Scholar

Panjabi, MM, Oxland, TR, Kifune, M, Arand, M, Wen, L, Chen, A. Validity of the three-column theory of thoracolumbar fractures. A biomechanic investigation. Spine 1995;20:1122–7. https://doi.org/10.1097/00007632-199505150-00003.Google Scholar

Tkaczuk, H. Tensile properties of human lumbar longitudinal ligaments. Acta Orthop Scand Suppl 1968;115:1+. https://doi.org/10.3109/ort.1968.39.suppl-115.01.Google Scholar

Virgin, WJ. Experimental investigations into the physical properties of the intervertebral disc. J Bone Joint Surg Br 1951;33-B:607–11. https://doi.org/10.1302/0301-620X.33B4.607.Google Scholar

Weaver, JK, Chalmers, J. Cancellous bone: its strength and changes with aging and an evaluation of some methods for measuring its mineral content. J Bone Joint Surg Am 1966;48(2):289–98.Google Scholar

White, AA, Johnson, RM, Panjabi, MM, Southwick, WO. Biomechanical analysis of clinical stability in the cervical spine. Clin Orthop 1975;109:85–96. https://doi.org/10.1097/00003086-197506000-00011.Google Scholar

White, AA, Panjabi, MM. The basic kinematics of the human spine. A review of past and current knowledge. Spine 1978;3:12–20. https://doi.org/10.1097/00007632-197803000-00003.Google Scholar

Adams, MM, Hicks, AL. Spasticity after spinal cord injury. Spinal Cord 2005;43(10):577–86. https://doi.org/10.1038/sj.sc.3101757.Google Scholar

Baron, EM, Young, WF. Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery 2007;60(1_Suppl.):35–42. https://doi.org/10.1227/01.NEU.0000215383.64386.82.Google Scholar

Brain, R, Knight, GC, Bull, JWD. Discussion on rupture of the intervertebral disc in the cervical region. J R Soc Med 1948;41(8):509–16.Google Scholar

Breig, A, Turnbull, I, Hassler, O. Effects of mechanical stresses on the spinal cord in cervical spondylosis. A study on fresh cadaver material. J Neurosurg 1966;25(1):45–56. https://doi.org/10.3171/jns.1966.25.1.0045.Google Scholar

Carette, S, Fehlings, MG. Cervical radiculopathy. N Engl J Med 2005;353(4):392–9. www.nejm.org/doi/abs/10.1056/NEJMcp043887Google Scholar

Chao, EYS. Biomechanics of the human gait. In Frontiers in Biomechanics. Springer, 1986: 225–44. https://doi.org/10.1007/978-1-4612-4866-8_17Google Scholar

Chen, I-H, Vasavada, A, Panjabi, MM. Kinematics of the cervical spine canal. J Spinal Disord 1994;7(2):93–101. http://journals.lww.com/00002517-199407020-00001Google Scholar

Choi, BW, Song, KJ, Chang, H. Ossification of the posterior longitudinal ligament: a review of literature. Asian Spine J 2011;5(4):267–76. https://doi.org/10.4184/asj.2011.5.4.267.Google Scholar

Clarke, E, Robinson, PK. Cervical myelopathy: a complication of cervical spondylosis. Brain 1956;79(3):483–510. https://doi.org/10.1093/brain/79.3.483.Google Scholar

Crandall, PH, Batzdorf, U. Cervical spondylotic myelopathy. J Neurosurg 1966;25(1):57–66. https://doi.org/10.3171/jns.1966.25.1.0057.Google Scholar

Dietz, V. Proprioception and locomotor disorders. Nat Rev Neurosci 2002;3(10):781–90. https://doi.org/10.1038/nrn939.Google Scholar

Dietz, V. Spinal cord pattern generators for locomotion. Clin Neurophysiol 2003;114(8):1379–89. https://doi.org/10.1016/s1388-2457(03)00120-2.Google Scholar

Ellingson, BM, Salamon, N, Woodworth, DC, Yokota, H, Holly, LT. Reproducibility, temporal stability, and functional correlation of diffusion MR measurements within the spinal cord in patients with asymptomatic cervical stenosis or cervical myelopathy. J Neurosurg Spine 2018;28(5):472–80. https://doi.org/10.3171/2017.7.SPINE176.Google Scholar

Ellingson, BM, Woodworth, DC, Leu, K, Salamon, N, Holly, LT. Spinal cord perfusion MR imaging implicates both ischemia and hypoxia in the pathogenesis of cervical spondylosis. World Neurosurg 2019;128:e773–81. https://doi.org/10.1016/j.wneu.2019.04.253Google Scholar

Fehlings, MG, Skaf, G. A review of the pathophysiology of cervical spondylotic myelopathy with insights for potential novel mechanisms drawn from traumatic spinal cord injury. Spine (Phila Pa 1976) 1998;23(24):2730–7. https://doi.org/10.1097/00007632-199812150-00012.Google Scholar

Gooding, MR, Wilson, CB, Hoff, JT. Experimental cervical myelopathy. Effects of ischemia and compression of the canine cervical spinal cord. J Neurosurg 2009;43(1):9–17. https://doi.org/10.3171/jns.1975.43.1.0009.Google Scholar

Hayashi, H, Okada, K, Hamada, M, Tada, K, Ueno, R. Etiologic factors of myelopathy. A radiographic evaluation of the aging changes in the cervical spine. Clin Orthop Relat Res 1987;214:200–09. www.ncbi.nlm.nih.gov/pubmed/3791744Google Scholar

Henneman, E, Olson, CB. Relations between structure and function in the design of skeletal muscles. J Neurophysiol 1965;28:581–98. https://doi.org/10.1152/jn.1965.28.3.581.Google Scholar

Holly, LT, Dong, Y, Albistegui-Dubois, R, Marehbian, J, Dobkin, B. Cortical reorganization in patients with cervical spondylotic myelopathy. J Neurosurg Spine 2007;6(6):544–51. https://thejns.org/view/journals/j-neurosurg-spine/6/6/article-p544.xmlGoogle Scholar

Holly, LT, Ellingson, BM, Salamon, N. Metabolic imaging using proton magnetic spectroscopy as a predictor of outcome after surgery for cervical spondylotic myelopathy. Clin Spine Surg 2017;30(5):E615–9. https://doi.org/10.1097/BSD.0000000000000248.Google Scholar

Holly, LT, Freitas, B, McArthur, D, Salamon, N. Proton magnetic resonance spectroscopy to evaluate spinal cord axonal injury in cervical spondylotic myelopathy. J Neurosurg Spine 2009;10:194–200. https://doi.org/10.3171/2008.12.SPINE08367.Google Scholar

Kandel, E, Schwartz, J, Jessell, TM. Principles of Neural Science. 4th ed. New York: McGraw-Hill; 2000.Google Scholar

Karadimas, S, Gialeli, C, Klironomos, G, et al. The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy. Curr Med Chem 2010;17(11):1048–58. https://doi.org/10.2174/092986710790820598.Google Scholar

Karadimas, SK, Gatzounis, G, Fehlings, MG. Pathobiology of cervical spondylotic myelopathy. Eur Spine J 2015;24(2):132–8. https://doi.org/10.1007/s00586-014-3264-4.Google Scholar

Karadimas, SK, Moon, ES, Yu, WR, et al. A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research. Neurobiol Dis 2013;54:43–58. http://dx.doi.org/10.1016/j.nbd.2013.02.013Google Scholar

Lemon, R. Cortical control of the primate hand. Exp Physiol 1993;78(3):263–263. https://doi.org/10.1113/expphysiol.1993.sp003686.Google Scholar

Little, JW, Ditunno, JF, Stiens, SA, Harris, RM. Incomplete spinal cord injury: neuronal mechanisms of motor recovery and hyperreflexia. Arch Phys Med Rehabil 1999;80(5):587–99. https://doi.org/10.1016/s0003-9993(99)90204-6.Google Scholar

Madhav, MS, Cowan, NJ. The synergy between neuroscience and control theory: the nervous system as inspiration for hard control challenges. Annu Rev Control Robot Auton Syst 2020;3(1):243–67. https://doi.org/10.1146/annurev-control-060117-104856.Google Scholar

Mair, WGP, Druckman, R. The pathology of spinal cord lesions and their relation to the clinical features. Brain 1953;76(1):70–91. https://doi.org/10.1093/brain/76.1.70.Google Scholar

Martin, J. Neuroanatomy (Text and Atlas). 3rd ed. McGraw-Hill Medical; 2003.Google Scholar